Recombinant anti-VLA4 antibody molecules
    2.
    发明授权
    Recombinant anti-VLA4 antibody molecules 失效
    重组抗VLA4抗体分子

    公开(公告)号:US08226950B2

    公开(公告)日:2012-07-24

    申请号:US12891284

    申请日:2010-09-27

    IPC分类号: A61K39/395 C07K16/28

    摘要: The present invention disclosed recombinant anti-VLA-4 antibody molecules, including humanized recombinant anti-VLA-4 antibody molecules. These antibodies are useful in the treatment of specific and non-specific inflammation, including asthma and inflammatory bowel disease. In addition, the humanized recombinant anti-VLA-4 antibodies disclosed can be useful in methods of diagnosing and localizing sites of inflammation.

    摘要翻译: 本发明公开了重组抗VLA-4抗体分子,包括人源化重组抗VLA-4抗体分子。 这些抗体可用于治疗特异性和非特异性炎症,包括哮喘和炎症性肠病。 此外,公开的人源化重组抗VLA-4抗体可用于诊断和定位炎症部位的方法。

    Recombinant anti-VLA-4 antibody molecules
    4.
    发明授权
    Recombinant anti-VLA-4 antibody molecules 失效
    重组抗VLA-4抗体分子

    公开(公告)号:US06602503B1

    公开(公告)日:2003-08-05

    申请号:US08454899

    申请日:1995-05-31

    IPC分类号: A61K39395

    摘要: The present invention disclosed recombinant anti-VLA-4 antibody molecules, including humanized recombinant anti-VLA-4 antibody molecules. These antibodies are useful in the treatment of specific and non-specific inflammation, including asthma and inflammatory bowel disease. In addition, the humanized recombinant anti-VLA-4 antibodies disclosed can be useful in methods of diagnosing and localizing sites of inflammation.

    摘要翻译: 本发明公开了重组抗VLA-4抗体分子,包括人源化重组抗VLA-4抗体分子。 这些抗体可用于治疗特异性和非特异性炎症,包括哮喘和炎症性肠病。 此外,公开的人源化重组抗VLA-4抗体可用于诊断和定位炎症部位的方法。

    Treatment for asthma with α4-specific antibodies
    9.
    发明授权
    Treatment for asthma with α4-specific antibodies 失效
    用α4特异性抗体治疗哮喘

    公开(公告)号:US07482003B2

    公开(公告)日:2009-01-27

    申请号:US11606388

    申请日:2006-11-29

    IPC分类号: A61K39/395 C07K16/28

    摘要: The present invention disclosed recombinant anti-VLA-4 antibody molecules, including humanized recombinant anti-VLA-4 antibody molecules. These antibodies are useful in the treatment of specific and non-specific inflammation, including asthma and inflammatory bowel disease. In addition, the humanized recombinant anti-VLA-4 antibodies disclosed can be useful in methods of diagnosing and localizing sites of inflammation.

    摘要翻译: 本发明公开了重组抗VLA-4抗体分子,包括人源化重组抗VLA-4抗体分子。 这些抗体可用于治疗特异性和非特异性炎症,包括哮喘和炎症性肠病。 此外,公开的人源化重组抗VLA-4抗体可用于诊断和定位炎症部位的方法。